Literature DB >> 30144514

Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.

Xi Liu1, Yulan Cheng2, John M Abraham2, Zhixiong Wang3, Zhe Wang2, Xiquan Ke4, Rong Yan5, Eun Ji Shin2, Saowanee Ngamruengphong2, Mouen A Khashab2, Guanjun Zhang6, George McNamara7, Andrew J Ewald8, DeChen Lin9, Zhengwen Liu10, Stephen J Meltzer11.   

Abstract

Primary organoid cultures generated from patient biopsies comprise a novel improved platform for disease modeling, being genetically stable and closely recapitulating in vivo scenarios. Barrett esophagus (BE) is the major risk factor for esophageal adenocarcinoma. There has been a dearth of long-term in vitro expansion models of BE neoplastic transformation. We generated a long-term virus-free organoid expansion model of BE neoplasia from patient biopsies. Both wild-type and paired APC-knockout (APCKO) BE organoids genome-edited by CRISPR-Cas9 showed characteristic goblet cell differentiation. Autonomous Wnt activation was confirmed in APCKO organoids by overexpression of Wnt target genes and nuclear-translocated β-catenin expression after withdrawal of Wnt-3A and R-spondin-1. Wnt-activated organoids demonstrated histologic atypia, higher proliferative and replicative activity, reduced apoptosis, and prolonged culturability. Wnt-activated organoids also showed sustained protrusive migration ability accompanied by disrupted basement membrane reorganization and integrity. This CRISPR-Cas9 editing human-derived organoid model recapitulates the critical role of aberrant Wnt/β-catenin signaling activation in BE neoplastic transformation. This system can be used to study other 'driver' pathway alterations in BE-associated neoplasia, avoiding signaling noise present in immortalized or cancer-derived cell lines.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Barrett esophagus; CRISPR/Cas9; Neoplastic transformation; Organoids; Wnt signaling

Mesh:

Substances:

Year:  2018        PMID: 30144514      PMCID: PMC6152930          DOI: 10.1016/j.canlet.2018.08.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  48 in total

1.  Wnt/beta-catenin and Fgf signaling control collective cell migration by restricting chemokine receptor expression.

Authors:  Andy Aman; Tatjana Piotrowski
Journal:  Dev Cell       Date:  2008-11       Impact factor: 12.270

2.  Sequential cancer mutations in cultured human intestinal stem cells.

Authors:  Jarno Drost; Richard H van Jaarsveld; Bas Ponsioen; Cheryl Zimberlin; Ruben van Boxtel; Arjan Buijs; Norman Sachs; René M Overmeer; G Johan Offerhaus; Harry Begthel; Jeroen Korving; Marc van de Wetering; Gerald Schwank; Meike Logtenberg; Edwin Cuppen; Hugo J Snippert; Jan Paul Medema; Geert J P L Kops; Hans Clevers
Journal:  Nature       Date:  2015-04-29       Impact factor: 49.962

3.  Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.

Authors:  R F Boynton; P L Blount; J Yin; V L Brown; Y Huang; Y Tong; T McDaniel; C Newkirk; J H Resau; W H Raskind; R C Haggitt; B J Reid; S J Meltzer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.

Authors:  K Kawakami; J Brabender; R V Lord; S Groshen; B D Greenwald; M J Krasna; J Yin; A S Fleisher; J M Abraham; D G Beer; D Sidransky; H T Huss; T R Demeester; C Eads; P W Laird; D H Ilson; D P Kelsen; D Harpole; M B Moore; K D Danenberg; P V Danenberg; S J Meltzer
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

5.  Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.

Authors:  M Esteller; A Sparks; M Toyota; M Sanchez-Cespedes; G Capella; M A Peinado; S Gonzalez; G Tarafa; D Sidransky; S J Meltzer; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

Review 6.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

Review 7.  Broad targeting of resistance to apoptosis in cancer.

Authors:  Ramzi M Mohammad; Irfana Muqbil; Leroy Lowe; Clement Yedjou; Hsue-Yin Hsu; Liang-Tzung Lin; Markus David Siegelin; Carmela Fimognari; Nagi B Kumar; Q Ping Dou; Huanjie Yang; Abbas K Samadi; Gian Luigi Russo; Carmela Spagnuolo; Swapan K Ray; Mrinmay Chakrabarti; James D Morre; Helen M Coley; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; William G Helferich; Xujuan Yang; Chandra S Boosani; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; W Nicol Keith; Alan Bilsland; Dorota Halicka; Somaira Nowsheen; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2015-04-28       Impact factor: 15.707

8.  Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.

Authors:  Pamela Riemer; Mattias Rydenfelt; Matthias Marks; Karen van Eunen; Kathrin Thedieck; Bernhard G Herrmann; Nils Blüthgen; Christine Sers; Markus Morkel
Journal:  J Cell Biol       Date:  2017-04-25       Impact factor: 10.539

9.  Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer.

Authors:  Jarno Drost; Ruben van Boxtel; Francis Blokzijl; Tomohiro Mizutani; Nobuo Sasaki; Valentina Sasselli; Joep de Ligt; Sam Behjati; Judith E Grolleman; Tom van Wezel; Serena Nik-Zainal; Roland P Kuiper; Edwin Cuppen; Hans Clevers
Journal:  Science       Date:  2017-09-14       Impact factor: 47.728

10.  Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Authors:  Austin M Dulak; Petar Stojanov; Shouyong Peng; Michael S Lawrence; Cameron Fox; Chip Stewart; Santhoshi Bandla; Yu Imamura; Steven E Schumacher; Erica Shefler; Aaron McKenna; Scott L Carter; Kristian Cibulskis; Andrey Sivachenko; Gordon Saksena; Douglas Voet; Alex H Ramos; Daniel Auclair; Kristin Thompson; Carrie Sougnez; Robert C Onofrio; Candace Guiducci; Rameen Beroukhim; Zhongren Zhou; Lin Lin; Jules Lin; Rishindra Reddy; Andrew Chang; Rodney Landrenau; Arjun Pennathur; Shuji Ogino; James D Luketich; Todd R Golub; Stacey B Gabriel; Eric S Lander; David G Beer; Tony E Godfrey; Gad Getz; Adam J Bass
Journal:  Nat Genet       Date:  2013-03-24       Impact factor: 38.330

View more
  17 in total

1.  Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.

Authors:  SriGanesh Jammula; Annalise C Katz-Summercorn; Xiaodun Li; Constanza Linossi; Elizabeth Smyth; Sarah Killcoyne; Daniele Biasci; Vinod V Subash; Sujath Abbas; Adrienn Blasko; Ginny Devonshire; Amber Grantham; Filip Wronowski; Maria O'Donovan; Nicola Grehan; Matthew D Eldridge; Simon Tavaré; Rebecca C Fitzgerald
Journal:  Gastroenterology       Date:  2020-02-04       Impact factor: 22.682

Review 2.  Cancer Risk and Mutational Patterns Following Organ Transplantation.

Authors:  Yangyang Shen; Di Lian; Kai Shi; Yuefeng Gao; Xiaoxiang Hu; Kun Yu; Qian Zhao; Chungang Feng
Journal:  Front Cell Dev Biol       Date:  2022-06-28

3.  A human Barrett's esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts.

Authors:  Qiuyang Zhang; Ajay Bansal; Kerry B Dunbar; Yan Chang; Jianning Zhang; Uthra Balaji; Jinghua Gu; Xi Zhang; Eitan Podgaetz; Zui Pan; Stuart Jon Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-04-05       Impact factor: 4.871

Review 4.  Convergence of human pluripotent stem cell, organoid, and genome editing technologies.

Authors:  Lin Wang; Zhaohui Ye; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-19

Review 5.  Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.

Authors:  Uma M Sachdeva; Masataka Shimonosono; Samuel Flashner; Ricardo Cruz-Acuña; Joel T Gabre; Hiroshi Nakagawa
Journal:  Cancer Lett       Date:  2021-04-07       Impact factor: 9.756

Review 6.  Organoid models of gastrointestinal cancers in basic and translational research.

Authors:  Harry Cheuk Hay Lau; Onno Kranenburg; Haipeng Xiao; Jun Yu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-25       Impact factor: 46.802

7.  Applications of Organoids for Cancer Biology and Precision Medicine.

Authors:  Yuan-Hung Lo; Kasper Karlsson; Calvin J Kuo
Journal:  Nat Cancer       Date:  2020-08-18

8.  A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.

Authors:  Mi Jian; Li Ren; Guodong He; Qi Lin; Wentao Tang; Yijiao Chen; Jingwen Chen; Tianyu Liu; Meiling Ji; Ye Wei; Wenju Chang; Jianmin Xu
Journal:  J Transl Med       Date:  2020-06-12       Impact factor: 5.531

9.  Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype.

Authors:  Ross J Porter; Graeme I Murray; Daniel P Brice; Russell D Petty; Mairi H McLean
Journal:  Br J Cancer       Date:  2019-12-13       Impact factor: 7.640

10.  Tumor organoids to study gastroesophageal cancer: a primer.

Authors:  Ramon U Jin; Jason C Mills
Journal:  J Mol Cell Biol       Date:  2020-08-01       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.